- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- hetero-3-3-3-3-1-1-mer
- Ligands
- 15 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 3 x NAG- NAG- BMA- MAN: alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
NAG-NAG-BMA-MAN.3: 8 residues within 4Å:- Chain C: S.179, L.231, N.232, N.346, C.413, V.414, S.415
- Ligands: NAG.28
1 PLIP interactions:1 interactions with chain C- Hydrogen bonds: C:G.348, C:V.414, C:S.179
NAG-NAG-BMA-MAN.9: 7 residues within 4Å:- Chain I: L.231, N.232, N.346, C.413, V.414, S.415
- Ligands: NAG.41
2 PLIP interactions:2 interactions with chain I- Hydrogen bonds: I:G.348, I:V.414
NAG-NAG-BMA-MAN.15: 8 residues within 4Å:- Chain K: E.181, L.231, N.232, N.346, G.348, C.413, V.414, S.415
2 PLIP interactions:2 interactions with chain K- Hydrogen bonds: K:G.348, K:V.414
- 39 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
NAG.19: 3 residues within 4Å:- Chain C: E.57, N.58
- Chain D: S.17
Ligand excluded by PLIPNAG.20: 3 residues within 4Å:- Chain C: S.120, F.121, N.122
Ligand excluded by PLIPNAG.21: 4 residues within 4Å:- Chain C: N.204, T.206, I.247, H.321
Ligand excluded by PLIPNAG.22: 6 residues within 4Å:- Chain C: Q.263, N.265, N.301, I.302, S.303, R.412
Ligand excluded by PLIPNAG.23: 3 residues within 4Å:- Chain C: N.271, L.292, V.410
Ligand excluded by PLIPNAG.24: 1 residues within 4Å:- Chain C: N.308
Ligand excluded by PLIPNAG.25: 1 residues within 4Å:- Chain C: N.324
Ligand excluded by PLIPNAG.26: 4 residues within 4Å:- Chain C: T.341, T.342, N.355, S.357
Ligand excluded by PLIPNAG.27: 3 residues within 4Å:- Chain C: Q.332, S.357, N.361
Ligand excluded by PLIPNAG.28: 6 residues within 4Å:- Chain C: N.232, P.261, V.414, S.415, N.416
- Ligands: NAG-NAG-BMA-MAN.3
Ligand excluded by PLIPNAG.29: 2 residues within 4Å:- Chain D: N.107, E.110
Ligand excluded by PLIPNAG.30: 4 residues within 4Å:- Chain D: N.114, M.115, T.116, Q.119
Ligand excluded by PLIPNAG.31: 4 residues within 4Å:- Chain D: K.122, E.123, S.125, N.126
Ligand excluded by PLIPNAG.32: 3 residues within 4Å:- Chain I: E.57, N.58
- Chain J: S.17
Ligand excluded by PLIPNAG.33: 3 residues within 4Å:- Chain I: S.120, F.121, N.122
Ligand excluded by PLIPNAG.34: 3 residues within 4Å:- Chain I: N.204, I.247, H.321
Ligand excluded by PLIPNAG.35: 6 residues within 4Å:- Chain I: Q.263, N.265, N.301, I.302, S.303, R.412
Ligand excluded by PLIPNAG.36: 3 residues within 4Å:- Chain I: N.271, L.292, V.410
Ligand excluded by PLIPNAG.37: 1 residues within 4Å:- Chain I: N.308
Ligand excluded by PLIPNAG.38: 1 residues within 4Å:- Chain I: N.324
Ligand excluded by PLIPNAG.39: 5 residues within 4Å:- Chain I: Q.332, T.342, N.355, S.357, W.387
Ligand excluded by PLIPNAG.40: 2 residues within 4Å:- Chain I: S.357, N.361
Ligand excluded by PLIPNAG.41: 6 residues within 4Å:- Chain I: N.232, P.261, V.414, S.415, N.416
- Ligands: NAG-NAG-BMA-MAN.9
Ligand excluded by PLIPNAG.42: 2 residues within 4Å:- Chain J: N.107, S.109
Ligand excluded by PLIPNAG.43: 3 residues within 4Å:- Chain J: N.114, M.115, T.116
Ligand excluded by PLIPNAG.44: 5 residues within 4Å:- Chain J: K.122, E.123, S.125, N.126, Y.127
Ligand excluded by PLIPNAG.45: 3 residues within 4Å:- Chain K: E.57, N.58
- Chain L: S.17
Ligand excluded by PLIPNAG.46: 3 residues within 4Å:- Chain K: S.120, F.121, N.122
Ligand excluded by PLIPNAG.47: 5 residues within 4Å:- Chain K: N.204, T.206, S.244, I.247, H.321
Ligand excluded by PLIPNAG.48: 5 residues within 4Å:- Chain K: Q.263, N.265, N.301, I.302, S.303
Ligand excluded by PLIPNAG.49: 3 residues within 4Å:- Chain K: N.271, L.292, V.410
Ligand excluded by PLIPNAG.50: 2 residues within 4Å:- Chain K: N.308, W.364
Ligand excluded by PLIPNAG.51: 1 residues within 4Å:- Chain K: N.324
Ligand excluded by PLIPNAG.52: 4 residues within 4Å:- Chain K: T.341, T.342, N.355, S.357
Ligand excluded by PLIPNAG.53: 3 residues within 4Å:- Chain K: S.357, G.358, N.361
Ligand excluded by PLIPNAG.54: 5 residues within 4Å:- Chain K: N.232, P.261, V.414, S.415, N.416
Ligand excluded by PLIPNAG.55: 2 residues within 4Å:- Chain L: N.107, E.110
Ligand excluded by PLIPNAG.56: 4 residues within 4Å:- Chain L: N.114, M.115, T.116, Q.119
Ligand excluded by PLIPNAG.57: 4 residues within 4Å:- Chain L: K.122, E.123, S.125, N.126
Ligand excluded by PLIP- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Steichen, J.M. et al., A generalized HIV vaccine design strategy for priming of broadly neutralizing antibody responses. Science (2019)
- Release Date
- 2019-11-06
- Peptides
- base-binding RM20A3 fragment antigen binding heavy chain: AGM
base-binding RM20A3 fragment antigen binding light chain: BHN
HIV-1 Env BG505 MD64 N332-GT5 SOSIP gp120: CIK
HIV-1 Env BG505 MD64 N332-GT5 SOSIP gp41: DJL
BG18-like precursor HMP42 fragment antigen binding heavy chain: E
BG18-like precursor HMP42 fragment antigen binding light chain: F - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
CG
JM
KB
DH
MN
NC
AI
EK
FD
BJ
GL
IE
HF
L
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- hetero-3-3-3-3-1-1-mer
- Ligands
- 15 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 3 x NAG- NAG- BMA- MAN: alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 39 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Steichen, J.M. et al., A generalized HIV vaccine design strategy for priming of broadly neutralizing antibody responses. Science (2019)
- Release Date
- 2019-11-06
- Peptides
- base-binding RM20A3 fragment antigen binding heavy chain: AGM
base-binding RM20A3 fragment antigen binding light chain: BHN
HIV-1 Env BG505 MD64 N332-GT5 SOSIP gp120: CIK
HIV-1 Env BG505 MD64 N332-GT5 SOSIP gp41: DJL
BG18-like precursor HMP42 fragment antigen binding heavy chain: E
BG18-like precursor HMP42 fragment antigen binding light chain: F - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
CG
JM
KB
DH
MN
NC
AI
EK
FD
BJ
GL
IE
HF
L